BIIB
Price
$185.01
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
GILD
Price
$88.76
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
Ad is loading...

BIIB vs GILD

Header iconBIIB vs GILD Comparison
Open Charts BIIB vs GILDBanner chart's image
Biogen
Price$185.01
Change-$0.00 (-0.00%)
Volume$1.89M
CapitalizationN/A
Gilead Sciences
Price$88.76
Change-$0.00 (-0.00%)
Volume$5.96M
CapitalizationN/A
View a ticker or compare two or three
BIIB vs GILD Comparison Chart
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BIIB vs. GILD commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Buy and GILD is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (BIIB: $185.01 vs. GILD: $88.76)
Brand notoriety: BIIB and GILD are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 159% vs. GILD: 84%
Market capitalization -- BIIB: $31.34B vs. GILD: $90.79B
BIIB [@Pharmaceuticals: Major] is valued at $31.34B. GILD’s [@Pharmaceuticals: Major] market capitalization is $90.79B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 1 FA rating(s) are green whileGILD’s FA Score has 4 green FA rating(s).

  • BIIB’s FA Score: 1 green, 4 red.
  • GILD’s FA Score: 4 green, 1 red.
According to our system of comparison, GILD is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 5 TA indicator(s) are bullish while GILD’s TA Score has 3 bullish TA indicator(s).

  • BIIB’s TA Score: 5 bullish, 3 bearish.
  • GILD’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, BIIB is a better buy in the short-term than GILD.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а +0.19% price change this week, while GILD (@Pharmaceuticals: Major) price change was +2.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.02%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +8.84%.

Reported Earning Dates

BIIB is expected to report earnings on Jan 30, 2025.

GILD is expected to report earnings on Feb 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.02% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GILD($90.8B) has a higher market cap than BIIB($31.3B). BIIB has higher P/E ratio than GILD: BIIB (26.95) vs GILD (16.20). GILD YTD gains are higher at: 13.094 vs. BIIB (-28.504). GILD has higher annual earnings (EBITDA): 10.5B vs. BIIB (2.04B). GILD has more cash in the bank: 7.26B vs. BIIB (1.05B). BIIB has less debt than GILD: BIIB (7.34B) vs GILD (25B). GILD has higher revenues than BIIB: GILD (27.1B) vs BIIB (9.84B).
BIIBGILDBIIB / GILD
Capitalization31.3B90.8B34%
EBITDA2.04B10.5B19%
Gain YTD-28.50413.094-218%
P/E Ratio26.9516.20166%
Revenue9.84B27.1B36%
Total Cash1.05B7.26B14%
Total Debt7.34B25B29%
FUNDAMENTALS RATINGS
BIIB vs GILD: Fundamental Ratings
BIIB
GILD
OUTLOOK RATING
1..100
484
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
10017
SMR RATING
1..100
7782
PRICE GROWTH RATING
1..100
6314
P/E GROWTH RATING
1..100
182
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GILD's Valuation (13) in the Biotechnology industry is significantly better than the same rating for BIIB (96). This means that GILD’s stock grew significantly faster than BIIB’s over the last 12 months.

GILD's Profit vs Risk Rating (17) in the Biotechnology industry is significantly better than the same rating for BIIB (100). This means that GILD’s stock grew significantly faster than BIIB’s over the last 12 months.

BIIB's SMR Rating (77) in the Biotechnology industry is in the same range as GILD (82). This means that BIIB’s stock grew similarly to GILD’s over the last 12 months.

GILD's Price Growth Rating (14) in the Biotechnology industry is somewhat better than the same rating for BIIB (63). This means that GILD’s stock grew somewhat faster than BIIB’s over the last 12 months.

GILD's P/E Growth Rating (2) in the Biotechnology industry is in the same range as BIIB (18). This means that GILD’s stock grew similarly to BIIB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIIBGILD
RSI
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
56%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 12 days ago
53%
Bullish Trend 5 days ago
57%
Declines
ODDS (%)
Bearish Trend 14 days ago
67%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
52%
View a ticker or compare two or three
Ad is loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
+1.83%
AMGN - BIIB
42%
Loosely correlated
+0.06%
OGN - BIIB
36%
Loosely correlated
+1.75%
GILD - BIIB
32%
Poorly correlated
-0.27%
AZN - BIIB
32%
Poorly correlated
+1.25%
NVS - BIIB
29%
Poorly correlated
+1.62%
More

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with JNJ. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
-0.27%
JNJ - GILD
41%
Loosely correlated
+0.45%
BMY - GILD
36%
Loosely correlated
+1.39%
BIIB - GILD
35%
Loosely correlated
+1.83%
ABBV - GILD
29%
Poorly correlated
+0.97%
AMGN - GILD
28%
Poorly correlated
+0.06%
More